Global Innovative Platforms (GIPL) Shares Outstanding (2020 - 2026)
Global Innovative Platforms' (GIPL) quarterly Shares Outstanding (Entity) came in at $49.8 million in Q2 2026, up 17.95% year-over-year from $42.2 million in Q2 2025, and up 2.2% quarter-over-quarter from $48.7 million in Q1 2026.
Analysis
Global Innovative Platforms (GIPL) Shares Outstanding (2020 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Shares Outstanding (Entity) across 7 years of filings, most recently posting $49.8 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 17.95% year-over-year to $49.8 million; the TTM figure through Jun 2026 stood at $49.8 million (up 17.95% YoY), while the FY2025 annual figure was $44.5 million, up 67.04% from the prior year.
- Shares Outstanding (Entity) came in at $49.8 million for Q2 2026 at Global Innovative Platforms, up from $48.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $49.8 million in Q2 2026 to a low of $619085.0 in Q1 2022.
- Average Shares Outstanding (Entity) over 5 years is $23.0 million, with a median of $27.0 million recorded in 2024.
- Year-over-year, Shares Outstanding (Entity) changed 0.0% in 2022 and jumped 4311.37% in 2024.
- Over 5 years, Shares Outstanding (Entity) stood at $619085.0 in 2022, then jumped by 3233.53% to $20.6 million in 2023, then surged by 80.75% to $37.3 million in 2024, then rose by 23.27% to $46.0 million in 2025, then gained by 8.2% to $49.8 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $49.8 million in Q2 2026, $48.7 million in Q1 2026, and $46.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 78.95 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 417.60 Mn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 499.50 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 40.55 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | 9.06 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | 47.35 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 48.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.78 Mn |
| Mar 31, 2026 | 46.72 Mn |
| Dec 31, 2025 | 44.54 Mn |
| Sep 30, 2025 | 39.37 Mn |
| Jun 30, 2025 | 40.44 Mn |
| Mar 31, 2025 | 38.43 Mn |
| Dec 31, 2024 | 35.75 Mn |
| Sep 30, 2024 | 26.63 Mn |
| Jun 30, 2024 | 27.31 Mn |
| Mar 31, 2024 | 27.31 Mn |
| Dec 31, 2023 | 20.64 Mn |
| Sep 30, 2023 | 619,085.00 |
| Jun 30, 2023 | 619,085.00 |
| Mar 31, 2023 | 619,085.00 |
| Dec 31, 2022 | 619,085.00 |
| Sep 30, 2022 | 619,085.00 |
| Jun 30, 2022 | 619,085.00 |
| Mar 31, 2022 | 619,085.00 |
| Dec 31, 2021 | 619,085.00 |
| Sep 30, 2021 | 619,085.00 |